Published online before print July 29, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Laboratorio de Patologia Celular, Instituto de Anatomia, Histologia and Patologia, and Institutos de
Fisiologia and
Farmacologia, Universidad Austral de Chile, Valdivia, Chile;
Departmento de Biologia Celular, Universidad de Concepcion, Chile; and
|| Lung Institute of Western Australia, Centre for Asthma and Allergy Research Institute, University of Western Australia, Perth, Australia
1. Correspondence: Laboratorio de Patologia Celular, Instituto de Anatomía, Histología and Patología, Universidad Austral de Chile, Casilla 567, Valdivia, Chile. E-mail: cfiguero{at}uach.cl
ABSTRACT
During neutrophil activation and degranulation, MMP-9 and MPO are released into the extracellular space to propagate inflammatory disorders. As kinin peptides are major participants in acute inflammatory responses, and the G-protein-coupled B1R mediates the chemotaxis of human neutrophils, we examined the release of the neutrophil enzymes MMP-9 and MPO by the B1R agonist LDBK and determined the signaling pathways that may regulate this cellular effect. Cytochalasin-treated and -untreated neutrophils were suspended in HBSS and stimulated with a range concentration of LDBK for 5 min. Zymography and Western blotting revealed that LDBK induced the release of MMP-9 and MPO. The use of specific signaling transduction inhibitors showed that release of MMP-9 depended on ERK1/2 and p38 MAPKs, whereas release of MPO involved only the p38 cascade. Inhibition of the key steps in these pathways showed that the release of both enzymes depended on PKC and PI3K. Stimulation of neutrophils with LDBK produced phosphorylation of ERK1/2 and p38 MAPK, which was inhibited by B1R antagonists. The phosphorylated ERK1/2 MAPK translocated to the neutrophil nucleus, suggesting that transcription of new genes may follow activation of B1R. Our results demonstrate that in human neutrophils, activation of kinin B1R by LDBK initiates separate signaling cascades that trigger the release of MMP-9 and MPO from tertiary and primary granules, respectively, suggesting that the B1R plays a pivotal role in inflammatory disorders.
Key Words: degranulation inflammation ERK1/2 MAPK p38 MAPK zymography